We performed gene annotation analysis of all novel non-recurrent HBV integrations, i.e., integrations in genes other than TERT, MLL4, and CCNE1. We identified 48 genic HBV integrations in 18 tumor samples and 29 normal samples (Table 1). This evidence concerns the gene CCNE1 and neoplasm.